Gapping down
In reaction to disappointing earnings/guidance: FDX -3.1%, AEMD -2.1%
M&A news: SIRO -5.3% (SIRO and XRAY to combine in an all-stock merger of equals in a ~$13.3 bln deal), XRAY -5.2%
In reaction to disappointing earnings/guidance: FDX -3.1%, AEMD -2.1%
M&A news: SIRO -5.3% (SIRO and XRAY to combine in an all-stock merger of equals in a ~$13.3 bln deal), XRAY -5.2%
Other news: PCYG -7.6% (lower following filing of amended 8-K containing letter from auditors to Board raising 'substantial doubt' about ReposiTrak's ability to continue as a going concern; ReposiTrak was acquired by Park City in May 2015), PAYC -5.4% (announced a 4.5 mln share secondary offering by mgmt and selling stockholders associated with Welsh, Carson, Anderson & Stowe X and WCAS Capital Partners IV), MRTX -2.4% (prices offering of 2,250,000 shares of common stock at $45.00 per share), UPS -2% (in sympathy with FDX after earnings), RAI -1.1% (announced disagreement with FDA ruling on four of its cigarette brands; 'We're examining all of our options at this time')
Analyst comments: PEB -2.3% (downgraded to Neutral at Cowen), SNDK -2.2% (downgraded to Neutral from Buy at Goldman), MNST -1.5% (downgraded to Outperform from Buy at Credit Agricole)
Analyst comments: PEB -2.3% (downgraded to Neutral at Cowen), SNDK -2.2% (downgraded to Neutral from Buy at Goldman), MNST -1.5% (downgraded to Outperform from Buy at Credit Agricole)